98 related articles for article (PubMed ID: 17180916)
1. [Synthesis of (24S)-hydroxy- and (24S)-24,25-epoxycholesterol analogues, potential agonists of nuclear LXR receptors].
Khripach VA; Zhabinskiĭ VN; Antonchik AV; Antonchik AP
Bioorg Khim; 2006; 32(6):651-9. PubMed ID: 17180916
[TBL] [Abstract][Full Text] [Related]
2. N-Acylthiadiazolines, a new class of liver X receptor agonists with selectivity for LXRbeta.
Molteni V; Li X; Nabakka J; Liang F; Wityak J; Koder A; Vargas L; Romeo R; Mitro N; Mak PA; Seidel HM; Haslam JA; Chow D; Tuntland T; Spalding TA; Brock A; Bradley M; Castrillo A; Tontonoz P; Saez E
J Med Chem; 2007 Aug; 50(17):4255-9. PubMed ID: 17665897
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and SAR of potent LXR agonists containing an indole pharmacophore.
Washburn DG; Hoang TH; Campobasso N; Smallwood A; Parks DJ; Webb CL; Frank KA; Nord M; Duraiswami C; Evans C; Jaye M; Thompson SK
Bioorg Med Chem Lett; 2009 Feb; 19(4):1097-100. PubMed ID: 19167885
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore analysis of the nuclear oxysterol receptor LXRalpha.
Spencer TA; Li D; Russel JS; Collins JL; Bledsoe RK; Consler TG; Moore LB; Galardi CM; McKee DD; Moore JT; Watson MA; Parks DJ; Lambert MH; Willson TM
J Med Chem; 2001 Mar; 44(6):886-97. PubMed ID: 11300870
[TBL] [Abstract][Full Text] [Related]
5. Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype.
Lund EG; Peterson LB; Adams AD; Lam MH; Burton CA; Chin J; Guo Q; Huang S; Latham M; Lopez JC; Menke JG; Milot DP; Mitnaul LJ; Rex-Rabe SE; Rosa RL; Tian JY; Wright SD; Sparrow CP
Biochem Pharmacol; 2006 Feb; 71(4):453-63. PubMed ID: 16325781
[TBL] [Abstract][Full Text] [Related]
6. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.
DiBlasio-Smith EA; Arai M; Quinet EM; Evans MJ; Kornaga T; Basso MD; Chen L; Feingold I; Halpern AR; Liu QY; Nambi P; Savio D; Wang S; Mounts WM; Isler JA; Slager AM; Burczynski ME; Dorner AJ; LaVallie ER
J Transl Med; 2008 Oct; 6():59. PubMed ID: 18925943
[TBL] [Abstract][Full Text] [Related]
7. Design, structure activity relationships and X-Ray co-crystallography of non-steroidal LXR agonists.
Bennett DJ; Carswell EL; Cooke AJ; Edwards AS; Nimz O
Curr Med Chem; 2008; 15(2):195-209. PubMed ID: 18220775
[TBL] [Abstract][Full Text] [Related]
8. Discovery and optimization of a novel series of liver X receptor-alpha agonists.
Li L; Liu J; Zhu L; Cutler S; Hasegawa H; Shan B; Medina JC
Bioorg Med Chem Lett; 2006 Mar; 16(6):1638-42. PubMed ID: 16386417
[TBL] [Abstract][Full Text] [Related]
9. SAR studies: designing potent and selective LXR agonists.
Szewczyk JW; Huang S; Chin J; Tian J; Mitnaul L; Rosa RL; Peterson L; Sparrow CP; Adams AD
Bioorg Med Chem Lett; 2006 Jun; 16(11):3055-60. PubMed ID: 16529931
[TBL] [Abstract][Full Text] [Related]
10. Discovery and SAR of cinnolines/quinolines as liver X receptor (LXR) agonists with binding selectivity for LXRbeta.
Hu B; Unwalla R; Collini M; Quinet E; Feingold I; Goos-Nilsson A; Wihelmsson A; Nambi P; Wrobel J
Bioorg Med Chem; 2009 May; 17(10):3519-27. PubMed ID: 19394832
[TBL] [Abstract][Full Text] [Related]
11. Liver X receptor agonists with selectivity for LXRbeta; N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides.
Swahn BM; Macsari I; Viklund J; Ohberg L; Sjödin J; Neelissen J; Lindquist J
Bioorg Med Chem Lett; 2009 Apr; 19(7):2009-12. PubMed ID: 19264481
[TBL] [Abstract][Full Text] [Related]
12. The pharmacology of LXR.
Michael LF; Schkeryantz JM; Burris TP
Mini Rev Med Chem; 2005 Aug; 5(8):729-40. PubMed ID: 16101409
[TBL] [Abstract][Full Text] [Related]
13. 2-Aryl-N-acyl indole derivatives as liver X receptor (LXR) agonists.
Kher S; Lake K; Sircar I; Pannala M; Bakir F; Zapf J; Xu K; Zhang SH; Liu J; Morera L; Sakurai N; Jack R; Cheng JF
Bioorg Med Chem Lett; 2007 Aug; 17(16):4442-6. PubMed ID: 17587573
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic opportunities for liver X receptor modulators.
Collins JL
Curr Opin Drug Discov Devel; 2004 Sep; 7(5):692-702. PubMed ID: 15503871
[TBL] [Abstract][Full Text] [Related]
15. Liver x receptors: potential novel targets in cardiovascular diseases.
Bruemmer D; Law RE
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Dec; 5(6):533-40. PubMed ID: 16503873
[TBL] [Abstract][Full Text] [Related]
16. Carboxylic acid based quinolines as liver X receptor modulators that have LXRbeta receptor binding selectivity.
Hu B; Quinet E; Unwalla R; Collini M; Jetter J; Dooley R; Andraka D; Nogle L; Savio D; Halpern A; Goos-Nilsson A; Wilhelmsson A; Nambi P; Wrobel J
Bioorg Med Chem Lett; 2008 Jan; 18(1):54-9. PubMed ID: 18023179
[TBL] [Abstract][Full Text] [Related]
17. RXR-LXR heterodimer modulators for the potential treatment of dyslipidemia.
Lagu B; Pio B; Lebedev R; Yang M; Pelton PD
Bioorg Med Chem Lett; 2007 Jun; 17(12):3497-503. PubMed ID: 17485209
[TBL] [Abstract][Full Text] [Related]
18. Indazole-based liver X receptor (LXR) modulators with maintained atherosclerotic lesion reduction activity but diminished stimulation of hepatic triglyceride synthesis.
Wrobel J; Steffan R; Bowen SM; Magolda R; Matelan E; Unwalla R; Basso M; Clerin V; Gardell SJ; Nambi P; Quinet E; Reminick JI; Vlasuk GP; Wang S; Feingold I; Huselton C; Bonn T; Farnegardh M; Hansson T; Nilsson AG; Wilhelmsson A; Zamaratski E; Evans MJ
J Med Chem; 2008 Nov; 51(22):7161-8. PubMed ID: 18973288
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and structure-activity relationship of podocarpic acid amides as liver X receptor agonists for potential treatment of atherosclerosis.
Liu W; Chen S; Dropinski J; Colwell L; Robins M; Szymonifka M; Hayes N; Sharma N; MacNaul K; Hernandez M; Burton C; Sparrow CP; Menke JG; Singh SB
Bioorg Med Chem Lett; 2005 Oct; 15(20):4574-8. PubMed ID: 16125384
[TBL] [Abstract][Full Text] [Related]
20. Lesion macrophages are a key target for the antiatherogenic effects of LXR agonists.
Bradley MN; Tontonoz P
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):10-1. PubMed ID: 15626767
[No Abstract] [Full Text] [Related]
[Next] [New Search]
